DTAN yields 1.81% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, DTAN + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DTAN + JNJ for your $10,000?
DTAN focuses on companies intangible-augmented intrinsic value, part of which is assessed through four pillars of intangible assets: (1) human capital, (2) brand equity, (3) intellectual property, and (4) network effects. Examples of these intangible assets are the narratives in corporate reports, patent and trademark grants, employee reviews, and social media. The adviser uses NLP, in addition to traditional quantitative investment techniques, to incorporate these data points into its investment process. The estimated value of each companys tangible assets, essentially the fifth pillar, is also included in determining the components of the portfolio. The process is applied to a starting universe of all publicly listed non-US companies. Then, at least 50 securities are selected to be included in its final portfolio, which may include common stocks and REITs.
Full DTAN Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.